NSNathan Christopher Shaner

Nathan Christopher Shaner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nathan Christopher Shaner has a total of 249 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Control of synaptic communication through molecularly engineered bioluminescence light emission and sensing

    by Ashley N. Slaviero, Mansi Prakash, Rachel Schumaker, Emmanuel L. Crespo, Alexander D. Silvagnoli, Maya O. Tree, Gerard G. Lambert, Christopher I. Moore, Nathan C. Shaner, Diane Lipscombe, et al.

    Synapses are sites of intercellular communication between neurons and from neurons to target organs, and of signal integration that underly physiological and behavioral responses. We have developed a modular platform, Interluminescence (Int), for experimental control of synaptic transmission: bioluminescent light, generated by a luciferase oxidizing a luciferin, from a presynaptic neuron is used to activate transsynaptic optogenetic ion channels in the postsynaptic neuron. Two strategies can modulate postsynaptic neurons in the presence of luciferin. In the ‘Act-Int’ approach, a luciferase is genetically expressed in synaptic vesicles and released during depolarization-induced presynaptic vesicle fusion and exocytosis. In the ‘Persist-Int’ approach, a luciferase is tethered to the presynaptic membrane where it can support sustained transsynaptic signaling. Both strategies can activate postsynaptic neurons with comparable efficacy under the conditions tested. By design, the modularity of the platform permits the use of luciferases and opsins ranging in brightness and light sensitivity, with the luciferase targeted to different subcellular regions of the presynaptic neuron, and the postsynaptic opsin being excitatory or inhibitory. Our results demonstrate the utility and versatility of Interluminescence to mediate synaptic transmission that is either activity-dependent or activity-independent.

  • Open Access

    CaBLAM: a high-contrast bioluminescent Ca2+ indicator derived from an engineered Oplophorus gracilirostris luciferase

    by Gerard G. Lambert, Emmanuel L. Crespo, Jeremy Murphy, Kevin L. Turner, Emily Gershowitz, Michaela Cunningham, Daniela Boassa, Selena Luong, Dmitrijs Celinskis, Justine J. Allen, et al.

    Monitoring intracellular calcium is central to understanding cell signaling across nearly all cell types and organisms. Fluorescent genetically encoded calcium indicators (GECIs) remain the standard tools for in vivo calcium imaging, but require intense excitation light, leading to photobleaching, background autofluorescence and phototoxicity. Bioluminescent GECIs, which generate light enzymatically, eliminate these artifacts but have been constrained by low dynamic range and suboptimal calcium affinities. Here we show that CaBLAM (‘calcium bioluminescence activity monitor’), an engineered bioluminescent calcium indicator, achieves an order-of-magnitude improvement in signal contrast and a tunable affinity matched to physiological cytosolic calcium. CaBLAM enables single-cell and subcellular activity imaging at video frame rates in cultured neurons and sustained imaging over hours in awake, behaving animals. These capabilities establish CaBLAM as a robust and general alternative to fluorescent GECIs, extending calcium imaging to regimes where excitation light is undesirable or infeasible.


  • Open Access

    Toward a brighter constellation: multiorgan neuroimaging of neural and vascular dynamics in the spinal cord and brain

    by Dmitrijs Celinskis, Christopher J. Black, Jeremy Murphy, Adriel Barrios-Anderson, Nina G. Friedman, Nathan C. Shaner, Carl Y. Saab, Manuel Gomez-Ramirez, David A. Borton, Christopher I. Moore

    SignificancePain comprises a complex interaction between motor action and somatosensation that is dependent on dynamic interactions between the brain and spinal cord. This makes understanding pain particularly challenging as it involves rich interactions between many circuits (e.g., neural and vascular) and signaling cascades throughout the body. As such, experimentation on a single region may lead to an incomplete and potentially incorrect understanding of crucial underlying mechanisms.AimWe aimed to develop and validate tools to enable detailed and extended observation of neural and vascular activity in the brain and spinal cord. The first key set of innovations was targeted to developing novel imaging hardware that addresses the many challenges of multisite imaging. The second key set of innovations was targeted to enabling bioluminescent (BL) imaging, as this approach can address limitations of fluorescent microscopy including photobleaching, phototoxicity, and decreased resolution due to scattering of excitation signals.ApproachWe designed 3D-printed brain and spinal cord implants to enable effective surgical implantations and optical access with wearable miniscopes or an open window (e.g., for one- or two-photon microscopy or optogenetic stimulation). We also tested the viability for BL imaging and developed a novel modified miniscope optimized for these signals (BLmini).ResultsWe describe “universal” implants for acute and chronic simultaneous brain–spinal cord imaging and optical stimulation. We further describe successful imaging of BL signals in both foci and a new miniscope, the “BLmini,” which has reduced weight, cost, and form-factor relative to standard wearable miniscopes.ConclusionsThe combination of 3D-printed implants, advanced imaging tools, and bioluminescence imaging techniques offers a coalition of methods for understanding spinal cord–brain interactions. Our work has the potential for use in future research into neuropathic pain and other sensory disorders and motor behavior.

  • Open Access

    Engineering luminopsins with improved coupling efficiencies

    by Ashley N. Slaviero, Nipun Gorantla, Jacob Simkins, Emmanuel L. Crespo, Ebenezer C. Ikefuama, Maya O. Tree, Mansi Prakash, Andreas Björefeldt, Lauren M. Barnett, Gerard G. Lambert, et al.

    Manipulation of neuronal activity in behaving experimental animals is crucial for elucidating neuronal networks underlying brain function. Both optogenetic1 and chemogenetic2 approaches continue to be highly valuable for identifying the contributions of genetically defined neuron populations to circuit and behavioral outputs. Both methods offer distinct advantages, with optogenetic control of the activity of subsets of neurons at precise temporal scales and slower chemogenetic control of the activity of entire populations of neurons across the brain. Previous work has developed a toolset that integrates opto- and chemogenetic approaches by fusing a light-emitting luciferase to an optogenetic light-responsive element, resulting in a luminescent opsin, or luminopsin (LMO)3 – 5 [Fig. 1(a)]. Bioluminescence produced by oxidation of a diffusible luciferin substrate by the luciferase enzyme activates a tethered, nearby opsin. Depending on the biophysical properties of the opsin, the light generated by the luciferase can either excite or inhibit target neurons expressing the LMO. Such integration of opto- and chemogenetic approaches allows manipulation of neural activity over a range of spatial and temporal scales of the same neurons in the same experimental animal. For example, the contribution to behavioral components of the activation of an entire population of neurons can be compared to those of a subset of the same neurons, activating the opsin chemogenetically through bioluminescence or optogenetically through light fibers.6


  • Open Access

    Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence

    by Andreas Björefeldt, Jeremy Murphy, Emmanuel L. Crespo, Gerard G. Lambert, Mansi Prakash, Ebenezer C. Ikefuama, Nina Friedman, Tariq M. Brown, Diane Lipscombe, Christopher I. Moore, et al.

    Understanding how specific cell types, circuits, and brain areas are involved in generating perception, action, and cognition requires approaches to experimentally manipulate spatiotemporal patterns of neural activity in genetically defined populations. At present, optogenetic and chemogenetic techniques constitute the major actuators used for this purpose, each with distinct strengths and limitations. Optogenetics notably offers the advantage of close to millisecond precision in the control of neural output.1,2 However, this approach requires invasive delivery of light, typically only practical to deliver in one to two locations in the brain or body. In comparison, chemogenetic approaches, including most notably designer receptors exclusively activated by designer drugs, DREADDs, provide sustained and minimally invasive modulation of neural populations distributed across much larger areas of the brain or body.3,4 To combine the strengths of above techniques and increase user flexibility, we have developed a bimodal strategy in which a luciferase-opsin fusion molecule (a luminopsin, LMO; Refs. 5 and 6) integrates opto- and chemogenetic features in a single actuator.7 With bioluminescent optogenetics (BL-OG), chemogenetic modulation of neural activity is achieved via delivery of a substrate, coelenterazine (CTZ), that is oxidized by the luciferase in the LMO, producing photons immediately adjacent to (within the same molecule) the optogenetic actuator. This approach allows the use of the same molecule for chemo- and optogenetic control at distinct times in the same animal or individually.8 – 11 As one example, Ref. 12 employed LMO3 to drive large-scale chemogenetic excitation of multiple cell types early in development and then revealed changes in local circuit dynamics after this developmental manipulation using optogenetics in the adult animal in vivo.12 Further, because actuation of BL-OG produces photons, users can track the time window of engagement by measuring this signal. Given the utility of this integrated single actuator approach, we sought to further improve its activation power.


  • Open Access

    Towards a Brighter Constellation: Multi-Organ Neuroimaging of Neural and Vascular Dynamics in the Spinal Cord and Brain

    by Dmitrijs Celinskis, Christopher J. Black, Jeremy Murphy, Adriel Barrios-Anderson, Nina Friedman, Nathan C. Shaner, Carl Saab, Manuel Gomez-Ramirez, Diane Lipscombe, David A. Borton, et al.

    Significance Pain is comprised of a complex interaction between motor action and somatosensation that is dependent on dynamic interactions between the brain and spinal cord. This makes understanding pain particularly challenging as it involves rich interactions between many circuits (e.g., neural and vascular) and signaling cascades throughout the body. As such, experimentation on a single region may lead to an incomplete and potentially incorrect understanding of crucial underlying mechanisms. Aim Here, we aimed to develop and validate new tools to enable detailed and extended observation of neural and vascular activity in the brain and spinal cord. The first key set of innovations were targeted to developing novel imaging hardware that addresses the many challenges of multi-site imaging. The second key set of innovations were targeted to enabling bioluminescent imaging, as this approach can address limitations of fluorescent microscopy including photobleaching, phototoxicity and decreased resolution due to scattering of excitation signals. Approach We designed 3D-printed brain and spinal cord implants to enable effective surgical implantations and optical access with wearable miniscopes or an open window (e.g., for one-or two-photon microscopy or optogenetic stimulation). We also tested the viability for bioluminescent imaging, and developed a novel modified miniscope optimized for these signals (BLmini). Results Here, we describe novel ‘universal’ implants for acute and chronic simultaneous brain-spinal cord imaging and optical stimulation. We further describe successful imaging of bioluminescent signals in both foci, and a new miniscope, the ‘BLmini,’ which has reduced weight, cost and form-factor relative to standard wearable miniscopes. Conclusions The combination of 3D printed implants, advanced imaging tools, and bioluminescence imaging techniques offers a new coalition of methods for understanding spinal cord-brain interactions. This work has the potential for use in future research into neuropathic pain and other sensory disorders and motor behavior.


  • Open Access

    Engineering luminopsins with improved coupling efficiencies

    by Ashley Slaviero, Nipun Gorantla, Jacob Simkins, Emmanuel L Crespo, Ebenezer C Ikefuama, Maya O Tree, Mansi Prakash, Andreas Björefeldt, Lauren M Barnett, Gerard G Lambert, et al.

    Significance Luminopsins (LMOs) are bioluminescent-optogenetic tools with a luciferase fused to an opsin that allow bimodal control of neurons by providing both optogenetic and chemogenetic access. Determining which design features contribute to the efficacy of LMOs will be beneficial for further improving LMOs for use in research. Aim We investigated the relative impact of luciferase brightness, opsin sensitivity, pairing of emission and absorption wavelength, and arrangement of moieties on the function of LMOs. Approach We quantified efficacy of LMOs through whole cell patch clamp recordings in HEK293 cells by determining coupling efficiency, the percentage of maximum LED induced photocurrent achieved with bioluminescent activation of an opsin. We confirmed key results by multielectrode array (MEAs) recordings in primary neurons. Results Luciferase brightness and opsin sensitivity had the most impact on the efficacy of LMOs, and N-terminal fusions of luciferases to opsins performed better than C-terminal and multi-terminal fusions. Precise paring of luciferase emission and opsin absorption spectra appeared to be less critical. Conclusions Whole cell patch clamp recordings allowed us to quantify the impact of different characteristics of LMOs on their function. Our results suggest that coupling brighter bioluminescent sources to more sensitive opsins will improve LMO function. As bioluminescent activation of opsins is most likely based on Förster resonance energy transfer (FRET), the most effective strategy for improving LMOs further will be molecular evolution of luciferase-fluorescent protein-opsin fusions.


  • Open Access

    CaBLAM! A high-contrast bioluminescent Ca 2+ indicator derived from an engineered Oplophorus gracilirostris luciferase

    by Gerard G. Lambert, Emmanuel L. Crespo, Jeremy Murphy, Kevin Turner, Emily Gershowitz, Michaela Cunningham, Daniela Boassa, Selena Luong, Dmitrijs Celinskis, Justine J. Allen, et al.

    Measuring ongoing cellular activity is essential to understanding the dynamic functions of biological organisms. The most popular current approach is imaging fluorescence-based genetically encoded Ca 2+ indicators (GECIs). While fluorescent probes are useful in many contexts, bioluminescence-based GECIs—probes that generate light through oxidation of a small-molecule by a luciferase or photoprotein—have several distinct advantages. Because bioluminescent (BL) GECIs do not use the bright extrinsic excitation light required for fluorescence, BL GECIs do not photobleach, do not suffer from nonspecific autofluorescent background, and do not cause phototoxicity. Further, BL GECIs can be applied in contexts where directly shining photons on an imaging target is not possible. Despite these advantages, the use of BL GECIs has to date been limited by their small changes in bioluminescence intensity, high baseline signal at resting Ca 2+ concentrations, and suboptimal Ca 2+ affinities. Here, we describe a new BL GECI, CaBLAM ( Ca 2+ B io L uminescence A ctivity M onitor), that displays much higher dynamic range than previous BL GECIs and has a Ca 2+ affinity suitable for capturing physiological changes in cytosolic Ca 2+ concentration. With these improvements, CaBLAM captures single-cell and subcellular resolution activity at high frame rates in cultured neurons and in vivo , and allows multi-hour recordings in mice and behaving zebrafish. This new advance provides a robust alternative to traditional fluorescent GECIs that can enable or enhance imaging across many experimental conditions.


  • Open Access

    Bioluminescent Genetically Encoded Glutamate Indicator for Molecular Imaging of Neuronal Activity

    by E. D. Petersen, A.P. Lapan, A.J. Fillion, E. L. Crespo, G. G. Lambert, A. Torreblanca Zanca, R. Orcutt, U. Hochgeschwender, N. C. Shaner, A. A. Gilad

    Genetically encoded optical sensors and advancements in microscopy instrumentation and techniques have revolutionized the scientific toolbox available for probing complex biological processes such as release of specific neurotransmitters. Most genetically encoded optical sensors currently used are based on fluorescence and have been highly successful tools for single-cell imaging in superficial brain regions. However, there remains a need to develop new tools for reporting neuronal activity in vivo within deeper structures without the need for hardware such as lenses or fibers to be implanted within the brain. Our approach to this problem is to replace the fluorescent elements of the existing biosensors with bioluminescent elements. This eliminates the need of external light sources to illuminate the sensor and overcomes several drawbacks of fluorescence imaging such as limited light penetration depth, excitation scattering, and tissue heating that are all associated with the external light needed for fluorescence imaging. Here we report the development of the first genetically encoded neurotransmitter indicators based on bioluminescent light emission. These probes exhibit robust changes in light output in response to extracellular presentation of the excitatory neurotransmitter glutamate. We expect this new approach to neurotransmitter indicator design to enable the engineering of specific bioluminescent probes for multiple additional neurotransmitters in the future, ultimately allowing neuroscientists to monitor activity associated with a specific neurotransmitter as it relates to behavior in a variety of neuronal and psychiatric disorders, among many other applications.


  • Open Access

    Aequorea’s secrets revealed: New fluorescent proteins with unique properties for bioimaging and biosensing

    by Gerard Lambert, Hadrien Depernet, Guillaume Gotthard, Darrin Schultz, Isabelle Navizet, Talley Lambert, Stephen Adams, Albertina Torreblanca-Zanca, Meihua Chu, Daphne Bindels, et al.

    Using mRNA sequencing and de novo transcriptome assembly, we identified, cloned, and characterized 9 previously undiscovered fluorescent protein (FP) homologs from Aequorea victoria and a related Aequorea species, with most sequences highly divergent from A. victoria green fluorescent protein (avGFP). Among these FPs are the brightest green fluorescent protein (GFP) homolog yet characterized and a reversibly photochromic FP that responds to UV and blue light. Beyond green emitters, Aequorea species express purple- and blue-pigmented chromoproteins (CPs) with absorbances ranging from green to far-red, including 2 that are photoconvertible. X-ray crystallography revealed that Aequorea CPs contain a chemically novel chromophore with an unexpected crosslink to the main polypeptide chain. Because of the unique attributes of several of these newly discovered FPs, we expect that Aequorea will, once again, give rise to an entirely new generation of useful probes for bioimaging and biosensing.